Press Release

United Kingdom Pharmaceutical Market to be dominated by OTC drugs till 2027

Extensive investment on R & D activities along with the novel product development is projected to bolster the growth of United Kingdom pharmaceutical market in the forecast period, 2023-2027. 

According to TechSci Research report,
United Kingdom Pharmaceutical Market- By Region, Competition Forecast & Opportunities, 2027, the United Kingdom pharmaceutical market is expected to witness growth at a significant rate in 2023-2027. Continuous medical innovations including precision medicine, cell and gene therapy and immuno-oncology are catering the new ways of prevention and detection with the potential to revolutionize the treatment of several diseases. Oncology, for instance, is still the largest pharmaceutical therapeutic area across globe with broad unmet needs and will most likely benefit from these novel therapies and innovation. These opportunities extend way beyond oncology to other therapeutic areas including cardiovascular, central nervous system, immunology, and rare diseases. Several drugs are becoming re-classified, shifting from a prescription-only medication to an over-the-counter medication, increases the market size of generic medication that correlates. Novel medications coming onto the market make up the difference in prescription medication market size.  Technology is increasingly becoming a prominent part of healthcare segment. Numerous apps assist users take their health in their own hands, by consulting medical experts through digital innovations in health, that are increasing consumer awareness and growing the pharmaceutical market.

However, United Kingdom pharmaceutical sector turnover slowed down, particularly due to the falling demand from the US when some significant drugs lost their patent protection, e.g., Novartis for Gleevec is restraining the market growth.

Browse over XX market data Figures spread through
 70 Pages and an in-depth TOC on "United Kingdom Pharmaceuticals Market"

The United Kingdom Pharmaceutical market is segmented into drug type, product type, application, distribution channel, regional distribution, and competitive landscape.

Based on drug type, the market is bifurcated into generic drugs and branded drugs. Based on product type, the market is divided into prescription drugs and over-the-counter drugs. Over the counter medications segment account for the largest share in the market, 2023-2027. This has been linked to the aging population requiring more OTC medications and consumer behaviors that encourage self-medication instead of visiting a doctor.

Based on application, the market is segmented into cardiovascular, musculoskeletal, oncology, anti-infective, metabolic disorder, others.
Metabolic disorder segment holds a significant share in the market in the forecast period, 2-23-2027.

Based on distribution channel, the market is divided into
retail pharmacy, hospital pharmacy, e-pharmacy. Retail pharmacy segment holds the greatest share in the market in the forecast period, 2023-2027. The United Kingdom pharmaceutical market is studied in major regions namely London, Southeast, East Anglia, Scotland, Southwest, East Midlands, Yorkshire & Humberside, Rest of United Kingdom.

Various key market players operating in the United Kingdom pharmaceutical market are:

·         Takeda Pharmaceutical Company Limited

·         GlaxoSmithKline Plc.

·         Vertex Pharmaceuticals (U.K.) Limited

·         Pfizer Limited

·         Novartis UK Limited

·         AstraZeneca UK Limited

·         Bristol-Myers Squibb Pharmaceuticals Limited

·         Roche Products Limited

·         Sanofi UK

·         Sun Pharmaceuticals UK Limited


Customers can also request for 10% free customization on this report.

The growing healthcare expenditures and the expanding number of private hospitals are driving the market growth. awareness towards early disease detection and treatment procedures are further supporting the market growth. In addition to this, the expanding geriatric population, who are more susceptible to various medical conditions, such as dementia, hypertension, cardiac failure, etc., is further escalating the demand for pharmaceuticals. Additionally, the introduction of government policies and reimbursement schemes across numerous countries for minimizing the cost of treatment for chronic diseases is also supporting the market growth. Moreover, the growing number of insurance companies in the pharma countries offering numerous insurance policies to decrease the out-of-the-pocket expenditures is further augmenting the demand of pharmaceuticals in these countries. The extensive investments in extensive R&D activities in the fields of biotechnology, immunology, oncology, etc., for the introduction of advanced treatments will continue to catalyze the market growth of pharmaceuticals across United Kingdom till 2027.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm”.

United Kingdom Pharmaceutical Market By Drug Type (Generic Drugs v/s Branded Drugs), By Product Type (Prescription Drugs v/s Over-The-Counter Drugs), By Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy), By Region, Competition Forecast & Opportunities, 2027" has analyzed the future growth potential of United Kingdom Prenatal & Neonatal Care Devices market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and assist decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with significant drivers, challenges, and opportunities in United Kingdom pharmaceutical market.


Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: [email protected]


Relevant Reports

Relevant News